La eritropoyetina es administrada por vía intraperitoneal.

Same author

The vulnerability of skin grafts to allo- and xeno-antibodies.

Immunology today·2014

Same author

Incidence and clinical course of de-novo malignancies in renal allograft recipients.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2001

Same author

Should polycystic kidneys ever be used for renal transplantation?

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·2001

Same author

Evaluation of clinical guidelines for the management of end-stage renal disease in europe: the EU BIOMED 1 study.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·2000

Same author

Outcome of renal transplantation.

Lancet (London, England)·2000

Same author

[Clinical thinking and decision-making in practice. A patient with arthritis, skin lesions and a perforated nasal septum].

Nederlands tijdschrift voor geneeskunde·1999

Same journal

Assisted dying and the silencing of medicine's next generation.

Lancet (London, England)·2026

Same journal

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Lancet (London, England)·2026

Same journal

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

Lancet (London, England)·2026

Same journal

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Lancet (London, England)·2026

Same journal

Research priorities for characterising Bundibugyo virus.

Lancet (London, England)·2026

Same journal

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Lancet (London, England)·2026

Videos de Experimentos Relacionados

La eritropoyetina es administrada por vía intraperitoneal.

Videos de Conceptos Relacionados

The vulnerability of skin grafts to allo- and xeno-antibodies.

Incidence and clinical course of de-novo malignancies in renal allograft recipients.

Should polycystic kidneys ever be used for renal transplantation?

Evaluation of clinical guidelines for the management of end-stage renal disease in europe: the EU BIOMED 1 study.

Outcome of renal transplantation.

[Clinical thinking and decision-making in practice. A patient with arthritis, skin lesions and a perforated nasal septum].

Assisted dying and the silencing of medicine's next generation.

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Videos de Experimentos Relacionados

La eritropoyetina es administrada por vía intraperitoneal.

Videos de Conceptos Relacionados

Artículos Relacionados

The vulnerability of skin grafts to allo- and xeno-antibodies.

Incidence and clinical course of de-novo malignancies in renal allograft recipients.

Should polycystic kidneys ever be used for renal transplantation?

Evaluation of clinical guidelines for the management of end-stage renal disease in europe: the EU BIOMED 1 study.

Outcome of renal transplantation.

[Clinical thinking and decision-making in practice. A patient with arthritis, skin lesions and a perforated nasal septum].

Assisted dying and the silencing of medicine's next generation.

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.